David Cunningham

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 49

Top Venues

British journal of cancer

Blood advances

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Guy's and Saint Thomas' NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Guy's and Saint Thomas' NHS Foundation Trust

United Kingdom

Training Programme Director :: Medical Oncology

Royal Marsden NHS Foundation Trust

United Kingdom

Director of the Royal Marsden/Institute of Cancer Research NIHR Biomedical Research Centre and Director of Clinical Research :: Research and Development

Institute of Cancer Research

United Kingdom

Professor Cancer Medicine

University of London

United Kingdom

Recognised Teacher :: Medical Oncology

Royal Marsden NHS Foundation Trust

United Kingdom

Head of GI and Lymphoma Units :: Gastrointestinal and Lymphoma Units, Department of Medicine

Royal Marsden NHS Foundation Trust

United Kingdom

Consultant Medical Oncologist :: Gastrointestinal and Lymphoma Units, Department of Medicine

Publications

Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Kai Tai Derek Yeung, Joseph Doyle, Sacheen Kumar, Katharine Aitken, Diana Tait, David Cunningham, Long R Jiao, Ricky Harminder Bhogal
Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma. Cancers 16 (2) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Susanna Slater, Annette Bryant, Maria Aresu, Ruwaida Begum, Hsiang-Chi Chen, Clare Peckitt, Retchel Lazaro-Alcausi, Paul Carter, Gayathri Anandappa, Shelize Khakoo, Lucinda Melcher, Vanessa Potter, Francisca M Marti, Joseph Huang, Graham Branagan, Nicol George, Muti Abulafi, Sarah Duff, Ashraf Raja, Ashish Gupta, Nicholas West, Leslie A Bucheit, Thereasa A Rich, Ian Chau, David Cunningham, Naureen Starling, null null
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Somaieh Hedayat, Luciano Cascione, David Cunningham, Heinz-Josef Lenz, Andrea Lampis, Jens Claus Hahne, Nina Tunariu, Sung Pil Hong, Silvia Marchetti, Khurum Khan, Elisa Fontana, Valentina Angerilli, Mia Delrieux, Daniel Nava Rodrigues, Letizia Procaccio, Sheela Rao, David Watkins, Naureen Starling, Ian Chau, Chiara Braconi, Nicos Fotiadis, Ruwaida Begum, Naomi Jayne Guppy, Louise Howell, Melanie Valenti, Scott Cribbes, Bernadett Kolozsvari, Vladimir Kirkin, Sara Lonardi, Michele Ghidini, Rodolfo Passalacqua, Raghad Elghadi, Luca Magnani, David James Pinato, Federica Di Maggio, Filippo Ghelardi, Elisa Sottotetti, Guglielmo Vetere, Paolo Ciracì, Georgios Vlachogiannis, Filippo Pietrantonio, Chiara Cremolini, Alessio Cortellini, Fotios Loupakis, Angelo Paolo Dei Tos, Nicola Valeri
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Somaieh Hedayat, Luciano Cascione, David Cunningham, Heinz-Josef Lenz, Andrea Lampis, Jens Claus Hahne, Nina Tunariu, Sung Pil Hong, Silvia Marchetti, Khurum Khan, Elisa Fontana, Valentina Angerilli, Mia Delrieux, Daniel Nava Rodrigues, Letizia Procaccio, Sheela Rao, David Watkins, Naureen Starling, Ian Chau, Chiara Braconi, Nicos Fotiadis, Ruwaida Begum, Naomi Jayne Guppy, Louise Howell, Melanie Valenti, Scott Cribbes, Bernadett Kolozsvari, Vladimir Kirkin, Sara Lonardi, Michele Ghidini, Rodolfo Passalacqua, Raghad Elghadi, Luca Magnani, David James Pinato, Federica Di Maggio, Filippo Ghelardi, Elisa Sottotetti, Guglielmo Vetere, Paolo Ciracì, Georgios Vlachogiannis, Filippo Pietrantonio, Chiara Cremolini, Alessio Cortellini, Fotios Loupakis, Angelo Paolo Dei Tos, Nicola Valeri
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Somaieh Hedayat, Luciano Cascione, David Cunningham, Heinz-Josef Lenz, Andrea Lampis, Jens Claus Hahne, Nina Tunariu, Sung Pil Hong, Silvia Marchetti, Khurum Khan, Elisa Fontana, Valentina Angerilli, Mia Delrieux, Daniel Nava Rodrigues, Letizia Procaccio, Sheela Rao, David Watkins, Naureen Starling, Ian Chau, Chiara Braconi, Nicos Fotiadis, Ruwaida Begum, Naomi Jayne Guppy, Louise Howell, Melanie Valenti, Scott Cribbes, Bernadett Kolozsvari, Vladimir Kirkin, Sara Lonardi, Michele Ghidini, Rodolfo Passalacqua, Raghad Elghadi, Luca Magnani, David James Pinato, Federica Di Maggio, Filippo Ghelardi, Elisa Sottotetti, Guglielmo Vetere, Paolo Ciracì, Georgios Vlachogiannis, Filippo Pietrantonio, Chiara Cremolini, Alessio Cortellini, Fotios Loupakis, Angelo Paolo Dei Tos, Nicola Valeri
Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Susanna Slater, Annette Bryant, Maria Aresu, Ruwaida Begum, Hsiang-Chi Chen, Clare Peckitt, Retchel Lazaro-Alcausi, Paul Carter, Gayathri Anandappa, Shelize Khakoo, Lucinda Melcher, Vanessa Potter, Francisca M Marti, Joseph Huang, Graham Branagan, Nicol George, Muti Abulafi, Sarah Duff, Ashraf Raja, Ashish Gupta, Nicholas West, Leslie A Bucheit, Thereasa A Rich, Ian Chau, David Cunningham, Naureen Starling
Tissue-free liquid biopsies combining genomic and methylation signals for minimal residual disease detection in patients with early colorectal cancer from the UK TRACC Part B study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie M Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances (2024)
Kai Tai Derek Yeung, Joseph Doyle, Sacheen Kumar, Katharine Aitken, Diana Tait, David Cunningham, Long R Jiao, Ricky Harminder Bhogal
Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma. Cancers 16 (2) (2024)
Susanna Slater, Annette Bryant, Maria Aresu, Ruwaida Begum, Hsiang-Chi Chen, Clare Peckitt, Retchel Lazaro-Alcausi, Paul Carter, Gayathri Anandappa, Shelize Khakoo, Lucinda Melcher, Vanessa Potter, Francisca M Marti, Joseph Huang, Graham Branagan, Nicol George, Muti Abulafi, Sarah Duff, Ashraf Raja, Ashish Gupta, Nicholas West, Leslie A Bucheit, Thereasa A Rich, Ian Chau, David Cunningham, Naureen Starling, null null
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Susanna Slater, Annette Bryant, Maria Aresu, Ruwaida Begum, Hsiang-Chi Chen, Clare Peckitt, Retchel Lazaro-Alcausi, Paul Carter, Gayathri Anandappa, Shelize Khakoo, Lucinda Melcher, Vanessa Potter, Francisca M Marti, Joseph Huang, Graham Branagan, Nicol George, Muti Abulafi, Sarah Duff, Ashraf Raja, Ashish Gupta, Nicholas West, Leslie A Bucheit, Thereasa A Rich, Ian Chau, David Cunningham, Naureen Starling, null null
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Pier Luigi Luigi Zinzani, Gilles Andre Salles, Alison J Moskowitz, Armando Santoro, Amitkumar Mehta, Paul M Barr, Neha Mehta-Shah, Graham P Collins, Stephen M Ansell, Joshua D Brody, Eva Domingo-Domenech, Nathalie A Johnson, David Cunningham, Silvia Ferrari, Julie Lisano, Jennifer Krajewski, Rachael Wen, Alev Akyol, Russell Crowe, Kerry Joane Savage
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma. Blood advances 8 (10) (2024)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer (2023)
Naureen Starling, David Cunningham
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri. British journal of cancer 128 (3) (2023)
Rohan Shotton, Rachel Broadbent, Alia Alchawaf, Mohamed Bakri Mohamed, Adam Gibb, Nicolás Martinez-Calle, Christopher Paul Fox, Mark Bishton, Alexandra Pender, Mary Gleeson, David Cunningham, Andrew John Davies, Sina Yadollahi, Toby Andrew Eyre, Graham P Collins, Faouzi Djebbari, Shireen Kassam, Paula Garland, Emily Watts, Wendy Osborne, William M Townsend, Rachael Pocock, Matthew J Ahearne, Fiona Miall, Xin Wang, Kim M Linton
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience. Blood advances (2023)
Pier Luigi Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A Johnson, Neha Mehta-Shah, Julie M Lisano, Rachael Wen, Alev Akyol, Alison J Moskowitz
Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up. Blood advances (2023)
Naureen Starling, David Cunningham
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri. British journal of cancer (2023)
Matthieu Faron, Maurice Cheugoua-Zanetsie, Jayne Tierney, Pierre Thirion, Matthew G Nankivell, Kathryn Winter, Hong Yang, Joel Shapiro, Dewi Vernerey, B Mark Smithers, Thomas Walsh, Guillaume Piessen, Magnus Nilsson, Jurjen J Boonstra, Marc Ychou, Simon Law, David Cunningham, Florent de Vathaire, Michael Stahl, Susan Urba, Michele Valmasoni, Danièle Williaume, Janine Thomas, Florian Lordick, Joel E Tepper, Jack Roth, Val Gebski, Bryan Burmeister, Xavier Paoletti, Johanna van Sandick, Jianhua Fu, Jean-Pierre Pignon, Michel Ducreux, Stefan Michiels, null null
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Naureen Starling, David Cunningham
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri. British journal of cancer 128 (3) (2023)
Jonathan L Moore, Michael Green, Aida Santaolalla, Harriet Deere, Richard P T Evans, Mona Elshafie, Anita Lavery, Damian T McManus, Andrew J McGuigan, Rosalie Douglas, Joanne Horne, Robert C Walker, Hira Mir, Monica Terlizzo, Sivesh Kathir Kamarajah, Mieke Van Hemelrijck, Nick Maisey, Ailsa Sita-Lumsden, Sarah Ngan, Mark Kelly, Cara R Baker, Sacheen Kumar, Jesper Lagergren, William H Allum, James A Gossage, Ewen Alexander Griffiths, Heike I Grabsch, Richard C Turkington, Timothy J Underwood, Elizabeth C Smyth, Rebecca C Fitzgerald, David Cunningham, Andrew R Davies
Pathological Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Naureen Starling, David Cunningham
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri. British journal of cancer (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
Avani Athauda, Matthew Nankivell, Rupert Langer, Susan Pritchard, Ruth E Langley, Katharina von Loga, Naureen Starling, Ian Chau, David Cunningham, Heike I Grabsch
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials. British journal of cancer (2023)
Naureen Starling, David Cunningham
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri. British journal of cancer 128 (3) (2023)
Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty, Giovanna Petrucci, David A Cameron, Alistair Ring, Howard G Kynaston, Duncan C Gilbert, Richard H Wilson, Richard A Hubner, Daniel E B Swinson, Siobhan Cleary, Alex Robbins, Mairead MacKenzie, Martin W G Scott-Brown, Sharmila Sothi, Lesley K Dawson, Lisa M Capaldi, Mark Churn, David Cunningham, Vincent Khoo, Anne C Armstrong, Nicola L Ainsworth, Gail Horan, Duncan A Wheatley, Russell Mullen, Fiona J Lofts, Axel Walther, Rebecca A Herbertson, John D Eaton, Ann O'Callaghan, Andrew Eichholz, Mohammed M Kagzi, Daniel M Patterson, Krishna Narahari, Jennifer Bradbury, Zuzana Stokes, Azhar J Rizvi, Georgina A Walker, Victoria L Kunene, Narayanan Srihari, Aleksandra Gentry-Maharaj, Angela Meade, Carlo Patrono, Bianca Rocca, Ruth E Langley
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial. British journal of cancer (2023)
Naureen Starling, David Cunningham
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhönen, T Kuitunen, P Nyandoto & M Kouri. British journal of cancer (2023)
Bianca Grosser, Jake Emmerson, Nic Gabriel Reitsam, David Cunningham, Matthew Nankivell, Ruth E Langley, William H Allum, Martin Trepel, Bruno Märkl, Heike I Grabsch
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial. British journal of cancer 130 (3) (2023)
John A Bridgewater, Peter Fletcher, Daniel H Palmer, Hassan Z Malik, K Raj Prasad, Darius F Mirza, Alan Anthony, Philippa Corrie, Stephen Falk, Meg Finch-Jones, Harpreet S Wasan, Paul J Ross, Lucy Wall, Jonathan Wadsley, Thomas R Evans, Deborah Stocken, Clive Stubbs, Raaj Praseedom, Yuk Ting Ma, Brian R Davidson, John P Neoptolemos, Timothy J Iveson, David Cunningham, O James Garden, Juan W Valle, John N Primrose, null null
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (18) (2022)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Arnaldo N S Silva, Yuichi Saito, Takaki Yoshikawa, Takashi Oshima, Jeremy D Hayden, Jan Oosting, Sophie Earle, Lindsay C Hewitt, Hayley L Slaney, Alexander I Wright, Imran Inam, Ruth E Langley, William Allum, Matthew G Nankivell, Gordon G A Hutchins, David Cunningham, Heike I Grabsch
Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma. The British journal of surgery 109 (3) (2022)
Mahmoud Elsawy, Julio C Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D Rudzki, Saurabh Dahiya, Kathleen A Dorritie, Samantha M Jaglowski, John Radford, Judith Trotman, David Cunningham, Alejandro Martin Martin Garcia-Sancho, Dimitrios Tzachanis, Matthew L Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thieblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei-Jhih Wang, Caitlyn T Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma. Blood 140 (21) (2022)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Pashtoon Murtaza Kasi, Gordon Fehringer, Hiroya Taniguchi, Naureen Starling, Yoshiaki Nakamura, Daisuke Kotani, Thomas Powles, Bob T Li, Lajos Pusztai, Vasily N Aushev, Ekaterina Kalashnikova, Shruti Sharma, Meenakshi Malhotra, Zachary P Demko, Alexey Aleshin, Angel A Rodriguez, Paul R Billings, Axel Grothey, Gilles Manceau, David Cunningham, Takayuki Yoshino, Scott Kopetz
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors. JCO precision oncology 6 (2022)
Annika Fendler, Lewis Au, Scott T C Shepherd, Fiona Byrne, Maddalena Cerrone, Laura Amanda Boos, Karolina Rzeniewicz, William Gordon, Benjamin Shum, Camille L Gerard, Barry Ward, Wenyi Xie, Andreas M Schmitt, Nalinie Joharatnam-Hogan, Georgina H Cornish, Martin A Pule, Leila Mekkaoui, Kevin W Ng, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Sarah Sarker, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Richard Stone, Camila Araujo De Carvalho Gomes, Helen R Flynn, Ana Agua-Doce, Philip Hobson, Simon Caidan, Michael Howell, Mary Y Wu, Robert Goldstone, Margaret Crawford, Laura Cubitt, Harshil Patel, Mike Gavrielides, Emma Nye, Ambrosius P Snijders, James I MacRae, Jérôme Nicod, Firza Gronthoud, Robyn L Shea, Christina Messiou, David Cunningham, Ian Chau, Naureen Starling, Nicholas Turner, Liam Welsh, Nicholas van As, Robin L Jones, Joanne Droney, Susana Banerjee, Kate C Tatham, Shaman Jhanji, Mary O'Brien, Olivia Curtis, Kevin J Harrington, Shreerang Bhide, Jessica Bazin, Anna Robinson, Clemency Stephenson, Tim Slattery, Yasir Khan, Zayd Tippu, Isla Leslie, Spyridon Gennatas, Alicia Okines, Alison Reid, Kate Young, Andrew J S Furness, Lisa M Pickering, Sonia Gandhi, Steven J Gamblin, Charles Swanton, null null, Emma Nicholson, Sacheen Kumar, Nadia Yousaf, Katalin Andrea Wilkinson, Anthony Swerdlow, Ruth Harvey, George Kassiotis, James Larkin, Robert J Wilkinson, Samra Turajlic, null null
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study. Nature cancer 2 (12) (2021)
Annika Fendler, Scott T C Shepherd, Lewis Au, Katalin Andrea Wilkinson, Mary Y Wu, Fiona Byrne, Maddalena Cerrone, Andreas M Schmitt, Nalinie Joharatnam-Hogan, Benjamin Shum, Zayd Tippu, Karolina Rzeniewicz, Laura Amanda Boos, Ruth Harvey, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Sarah Sarker, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Justine Korteweg, Tara Foley, Jessica Bazin, William Gordon, Taja Barber, Andrea Emslie-Henry, Wenyi Xie, Camille L Gerard, Daqi Deng, Emma C Wall, Ana Agua-Doce, Sina Namjou, Simon Caidan, Mike Gavrielides, James I MacRae, Gavin P Kelly, Kema Peat, Denise Kelly, Aida Murra, Kayleigh Kelly, Molly O'Flaherty, Lauren Dowdie, Natalie Ash, Firza Gronthoud, Robyn L Shea, Gail Gardner, Darren Murray, Fiona Kinnaird, Wanyuan Cui, Javier Pascual, Simon Rodney, Justin Mencel, Olivia Curtis, Clemency Stephenson, Anna Robinson, Bhavna Oza, Sheima Farag, Isla Leslie, Aljosja Rogiers, Sunil Iyengar, Mark Ethell, Christina Messiou, David Cunningham, Ian Chau, Naureen Starling, Nicholas Turner, Liam Welsh, Nicholas van As, Robin L Jones, Joanne Droney, Susana Banerjee, Kate C Tatham, Mary O'Brien, Kevin Harrington, Shreerang Bhide, Alicia Okines, Alison Reid, Kate Young, Andrew J S Furness, Lisa M Pickering, Charles Swanton, null null, Sonia Gandhi, Steven J Gamblin, David L V Bauer, George Kassiotis, Sacheen Kumar, Nadia Yousaf, Shaman Jhanji, Emma Nicholson, Michael Howell, Susanna Walker, Robert J Wilkinson, James Larkin, Samra Turajlic, null null
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nature cancer 2 (12) (2021)
Manish A Shah, Gyorgy Bodoky, Alexander Starodub, David Cunningham, Desmond Yip, Zev A Wainberg, Johanna Bendell, Dung Thai, Joyce He, Pankaj Bhargava, Jaffer A Ajani
Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
Thomas Millard, Fatin Sammour, Chloe Anthias, Sandra Easdale, Carlos Gonzalez-Arias, Mark Ethell, Mike Potter, Sunil Iyengar, Dima El-Sharkawi, Ayoma D Attygalle, Ian Chau, David Cunningham, Emma Nicholson, Bhupinder Sharma
Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma? Bone marrow transplantation (2021)
Andrew Woolston, Louise J Barber, Beatrice Griffiths, Oriol Pich, Nuria Lopez-Bigas, Nik Matthews, Sheela Rao, David Watkins, Ian Chau, Naureen Starling, David Cunningham, Marco Gerlinger
Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer. Nature ecology & evolution 5 (7) (2021)
Alexandros Georgiou, Adam Stewart, Georgios Vlachogiannis, Lisa Pickard, Nicola Valeri, David Cunningham, Steven R Whittaker, Udai Banerji
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer. Cellular oncology (Dordrecht) 44 (5) (2021)
Pietro Carotenuto, Francesco Amato, Andrea Lampis, Colin Rae, Somaieh Hedayat, Maria C Previdi, Domenico Zito, Maya Raj, Vincenza Guzzardo, Francesco Sclafani, Andrea Lanese, Claudia Parisi, Caterina Vicentini, Ian Said-Huntingford, Jens C Hahne, Albert Hallsworth, Vladimir Kirkin, Kate Young, Ruwaida Begum, Andrew Wotherspoon, Kyriakos Kouvelakis, Sergio Xavier Azevedo, Vasiliki Michalarea, Rosanna Upstill-Goddard, Sheela Rao, David Watkins, Naureen Starling, Anguraj Sadanandam, David K Chang, Andrew V Biankin, Nigel B Jamieson, Aldo Scarpa, David Cunningham, Ian Chau, Paul Workman, Angelo Paolo Dei Tos, Nicola Valeri, Chiara Braconi
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage. Nature communications 12 (1) (2021)
Elisa Fontana, Gift Nyamundanda, David Cunningham, Dongsheng Tu, Maggie Chon U Cheang, Derek J Jonker, Lillian L Siu, Francesco Sclafani, Katherine Eason, Chanthirika Ragulan, Maria Antonietta Bali, Sanna Hulkki-Wilson, Jonathan M Loree, Paul M Waring, Mirella Giordano, Patrick Lawrence, Daniel Nava Rodrigues, Ruwaida Begum, Jeremy D Shapiro, Timothy J Price, Chiara Cremolini, Naureen Starling, Filippo Pietrantonio, Livio Trusolino, Christopher J O'Callaghan, Anguraj Sadanandam
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial. JCO precision oncology 4 (2020)
Timothy J Iveson, Kathleen Anne Boyd, Rachel S Kerr, Jose Antonio Robles-Zurita, Mark P Saunders, Andrew H Briggs, Jim Cassidy, Niels Henrik Hollander, Josep Tabernero, Andrew Haydon, Bengt Glimelius, Andrea Harkin, Karen Allan, John McQueen, Sarah Pearson, Ashita Waterston, Louise Medley, Charles Wilson, Richard Ellis, Sharadah Essapen, Amandeep S Dhadda, Mark Harrison, Stephen Falk, Sherif Raouf, Charlotte Rees, Rene K Olesen, David J Propper, John A Bridgewater, Ashraf Azzabi, David Farrugia, Andrew Webb, David Cunningham, Tamas Hickish, Andrew Weaver, Simon Gollins, Harpreet S Wasan, James Paul
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. Health technology assessment (Winchester, England) 23 (64) (2020)
Alexandros Georgiou, Adam Stewart, David Cunningham, Udai Banerji, Steven R Whittaker
Inactivation of NF1 Promotes Resistance to EGFR Inhibition in KRAS/NRAS/BRAFV600 -Wild-Type Colorectal Cancer. Molecular cancer research : MCR 18 (6) (2020)

David Cunningham.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Cunningham